The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 17, 2020
Filed:
Jun. 18, 2019
Applicant:
Oncology Venture Aps, Høsholm, DK;
Inventors:
Steen Knudsen, Scottsdale, AZ (US);
Peter Buhl Jensen, Farum, DK;
Assignee:
Oncology Venture ApS, Hørsholm, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/498 (2006.01); A61P 35/00 (2006.01); C12Q 1/6837 (2018.01); G16H 50/30 (2018.01); G01N 33/50 (2006.01); C12Q 1/6886 (2018.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/498 (2013.01); A61P 35/00 (2018.01); C12Q 1/6837 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5023 (2013.01); G16H 50/30 (2018.01); A61K 45/06 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention features methods, devices, and kits for detecting gene expression in a patient with a cancer or determining responsive of a patient with a cancer to a treatment, such as treatment with dovitinib or a pharmaceutically acceptable salt thereof. The invention further includes methods of treating a patient with a cancer by administering a treatment, e.g., treatment with dovitinib or a pharmaceutically acceptable salt thereof, in particular when the patient is determined to be responsive to the treatment based on the expression of the biomarkers described herein.